668 related articles for article (PubMed ID: 8734158)
1. Is there a need for new antiarrhythmic drugs?
Roden DM
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
[TBL] [Abstract][Full Text] [Related]
2. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
Brachmann J
Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
[TBL] [Abstract][Full Text] [Related]
3. What have clinical trials taught us about proarrhythmia?
Skanes AC; Green MS
Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic management of arrhythmias.
Bink-Boelkens MT
Pediatr Cardiol; 2000; 21(6):508-15. PubMed ID: 11050274
[TBL] [Abstract][Full Text] [Related]
5. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Shah SA; Kluger J; White CM
Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
[TBL] [Abstract][Full Text] [Related]
6. Future of antiarrhythmic drugs.
Darbar D; Roden DM
Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
8. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
9. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P
Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434
[No Abstract] [Full Text] [Related]
10. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
Shu J; Zhou J; Patel C; Yan GX
Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
[TBL] [Abstract][Full Text] [Related]
11. A benefit-risk assessment of class III antiarrhythmic agents.
Elming H; Brendorp B; Pehrson S; Pedersen OD; Køber L; Torp-Petersen C
Expert Opin Drug Saf; 2004 Nov; 3(6):559-77. PubMed ID: 15500415
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone as paradigm for developing new drugs for atrial fibrillation.
Singh BN
J Cardiovasc Pharmacol; 2008 Oct; 52(4):300-5. PubMed ID: 18841075
[TBL] [Abstract][Full Text] [Related]
13. [Ion channels and arrhythmias].
Borchard U; Hafner D
Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
Kosior D; Opolski G; Torbicki A
Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
[TBL] [Abstract][Full Text] [Related]
15. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
Scholz H
Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
[TBL] [Abstract][Full Text] [Related]
16. Hybrid therapy of atrial fibrillation.
Santini M; Pignalberi C; Ricci R; Calò L
Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
[TBL] [Abstract][Full Text] [Related]
17. Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
Farkas A; Leprán I; Papp JG
J Cardiovasc Pharmacol; 2002 Feb; 39(2):287-97. PubMed ID: 11791015
[TBL] [Abstract][Full Text] [Related]
18. New antiarrhythmic drugs.
Flaker GC; Munuswamy K
Am Fam Physician; 1982 Nov; 26(5):226-32. PubMed ID: 7148632
[No Abstract] [Full Text] [Related]
19. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
[TBL] [Abstract][Full Text] [Related]
20. [Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
Motté G
Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():7-16. PubMed ID: 6280631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
